Vertex Pharmaceuticals Incorporated:企業の戦略・SWOT・財務情報

◆英語タイトル:Vertex Pharmaceuticals Incorporated - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4460
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Vertex Pharmaceuticals Incorporated – Strategy, SWOT and Corporate Finance Report
Summary

Vertex Pharmaceuticals Incorporated – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Vertex Pharmaceuticals Incorporated (Vertex or ‘the company’) is a biotechnology company engaged in the discovery, development and commercialization of new medicines. Vertex operates R&D facilities in California, Washington D.C., Iowa, Canada, Switzerland, the UK, France, Germany, Australia, Ireland, Spain, Italy and the Netherlands. The company primarily operates in the US, Canada and Europe. It is headquartered in Boston, Massachusetts.

Scope

- Detailed information on Vertex Pharmaceuticals Incorporated required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Vertex Pharmaceuticals Incorporated in the form of a SWOT analysis
- An in-depth view of the business model of Vertex Pharmaceuticals Incorporated including a breakdown and examination of key business segments
- Intelligence on Vertex Pharmaceuticals Incorporated’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Vertex Pharmaceuticals Incorporated, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Vertex Pharmaceuticals Incorporated and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Vertex Pharmaceuticals Incorporated as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Vertex Pharmaceuticals Incorporated’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Vertex Pharmaceuticals Incorporated: Company Overview 9
Vertex Pharmaceuticals Incorporated: Overview and Key Facts 9
Vertex Pharmaceuticals Incorporated: Overview 9
Vertex Pharmaceuticals Incorporated: Key Facts 9
Vertex Pharmaceuticals Incorporated: Key Employees 10
Vertex Pharmaceuticals Incorporated: Key Employee Biographies 12
Vertex Pharmaceuticals Incorporated: Major Products and Services 20
Vertex Pharmaceuticals Incorporated: Company History 21
Vertex Pharmaceuticals Incorporated: Management Statement 27
Vertex Pharmaceuticals Incorporated: Locations and Subsidiaries 29
Vertex Pharmaceuticals Incorporated: Key Competitors 30
Vertex Pharmaceuticals Incorporated: Company Analysis 31
Vertex Pharmaceuticals Incorporated: Business Description 31
Vertex Pharmaceuticals Incorporated: SWOT Analysis 33
Vertex Pharmaceuticals Incorporated: SWOT Overview 33
Vertex Pharmaceuticals Incorporated: Strengths 33
Vertex Pharmaceuticals Incorporated: Weaknesses 34
Vertex Pharmaceuticals Incorporated: Opportunities 34
Vertex Pharmaceuticals Incorporated: Threats 34
Vertex Pharmaceuticals Incorporated: Corporate Financial Deals Activity 36
Vertex Pharmaceuticals Incorporated: Financial Deals Overview 36
Vertex Pharmaceuticals Incorporated: Targets and Partners 38
Vertex Pharmaceuticals Incorporated: Top Deals 2014 – 2018YTD* 39
Vertex Pharmaceuticals Incorporated: Mergers and Acquisitions 40
Vertex Pharmaceuticals Incorporated: Corporate Venturing 41
Vertex Pharmaceuticals Incorporated: Partnership 42
Vertex Pharmaceuticals Incorporated: Recent Developments 43
Vertex Pharmaceuticals Incorporated: News and Events Summary 43
Vertex Pharmaceuticals Incorporated: Business Expansion 46
Vertex Pharmaceuticals Incorporated: Corporate Governance 47
Vertex Pharmaceuticals Incorporated: Corporate Social Responsibility 47
Vertex Pharmaceuticals Incorporated: Financial Performance 49
Vertex Pharmaceuticals Incorporated: Grants 50
Vertex Pharmaceuticals Incorporated: Strategy and Operations 51
Appendix 52
Contact Us 52
Methodology 52
About MarketLine 53

List of Tables
Table 1: Vertex Pharmaceuticals Incorporated: Key Facts
Table 2: Vertex Pharmaceuticals Incorporated: Key Employees
Table 3: Vertex Pharmaceuticals Incorporated: Locations and Subsidiaries
Table 4: Vertex Pharmaceuticals Incorporated: Key Competitors
Table 5: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Vertex Pharmaceuticals Incorporated: M&A Average Deal Size - Value (US$m)
Table 8: Vertex Pharmaceuticals Incorporated: Targets and Partners
Table 9: Vertex Pharmaceuticals Incorporated: Top Deals 2014 - 2018YTD*
Table 10: Vertex Pharmaceuticals Incorporated: M&A Volume and Value Trend (2014 - YTD*2018)
Table 11: Vertex Pharmaceuticals Incorporated: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 12: Vertex Pharmaceuticals Incorporated: Corporate Venturing by Geography (2014 - YTD*2018)
Table 13: Vertex Pharmaceuticals Incorporated: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 14: Vertex Pharmaceuticals Incorporated: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 15: Vertex Pharmaceuticals Incorporated: News and Events Summary
Table 16: Vertex Pharmaceuticals Incorporated: Business Expansion
Table 17: Vertex Pharmaceuticals Incorporated: Corporate Governance
Table 18: Vertex Pharmaceuticals Incorporated: Corporate Social Responsibility
Table 19: Vertex Pharmaceuticals Incorporated: Financial Performance
Table 20: Vertex Pharmaceuticals Incorporated: Grants
Table 21: Vertex Pharmaceuticals Incorporated: Strategy and Operations

List of Figures
Figure 1: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Vertex Pharmaceuticals Incorporated: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Vertex Pharmaceuticals Incorporated: M&A Average Deal Size - Value (US$m)
Figure 4: Vertex Pharmaceuticals Incorporated: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Vertex Pharmaceuticals Incorporated: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 6: Vertex Pharmaceuticals Incorporated: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 7: Vertex Pharmaceuticals Incorporated: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 8: Vertex Pharmaceuticals Incorporated: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Vertex Pharmaceuticals Incorporated:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Trevena Inc (TRVN):企業の財務・戦略的SWOT分析
    Summary Trevena Inc (Trevena) is a biotechnology company that discovers and develops G-protein coupled receptor targeted medicines. The company provides products such as RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination w …
  • Avara Pharmaceutical Services Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avara Pharmaceutical Services Inc (Avara) is a contract development and manufacturing organization that provides primary formulation and manufacturing, secondary manufacturing and packaging of small molecules. It offers wide range of services such as manufacturing of active pharmaceutical in …
  • Eleison Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Eleison Pharmaceuticals LLC (Eleison Pharmaceuticals) is a drug development company that acquires, develops, and commercializes clinical stage drug candidates for orphan cancers. The company’s pipeline products include glufosfamide and inhaled lipid-complexed cisplatin. Its glufosfamide is a …
  • Fugro GeoServices Ltd:企業の戦略的SWOT分析
    Fugro GeoServices Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Bioanalytical Systems Inc (BASI):企業の財務・戦略的SWOT分析
    Summary Bioanalytical Systems Inc (Bioanalytical Systems) is a contract research organization that provides drug discovery and development services, and analytical instruments. The company’s contract research services include screening and pharmacological testing, formulation development, preclinica …
  • Neurones SA (NRO):企業の財務・戦略的SWOT分析
    Neurones SA (NRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ceres Power Holdings plc (CWR):企業の財務・戦略的SWOT分析
    Summary Ceres Power Holdings Plc (Ceres Power) is an alternative energy company that develops low cost and next generation fuel cell technologies. The company carries out developing steel cell a fuel cell technology that converts natural gas and hydrogen fuel directly into electrical power and heat …
  • Knoll Inc (KNL):企業の財務・戦略的SWOT分析
    Knoll Inc (KNL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Dongsung Pharm Co Ltd (002210):企業の財務・戦略的SWOT分析
    Dongsung Pharm Co Ltd (002210) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Punjab National Bank (PNB):企業の財務・戦略的SWOT分析
    Punjab National Bank (PNB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • TTCL Public Company Limited (TTCL):電力:M&Aディール及び事業提携情報
    Summary TTCL Public Company Limited (TTCL), a subsidiary of Italian-Thai Development Public Company Limited, is a provider of engineering and construction services. The company offers integrated engineering, procurement and construction (EPC) services, feasibility study and project management servic …
  • Cellectis SA (ALCLS):医療機器:M&Aディール及び事業提携情報
    Summary Cellectis SA (Cellectis) is a clinical-stage biopharmaceutical company that research, develop and commercialise rational genome engineering technologies. The company pioneers gene editing company, deploying core proprietary technologies to develop off-the-shelf immunotherapies to target and …
  • Virginia Electric and Power Company:発電所・企業SWOT分析
    Virginia Electric and Power Company – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • The Procter & Gamble Co:戦略・SWOT・企業財務分析
    The Procter & Gamble Co - Strategy, SWOT and Corporate Finance Report Summary The Procter & Gamble Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • MGC Diagnostics Corp (MGCD):企業の財務・戦略的SWOT分析
    Summary MGC Diagnostics Corp (MGC Diagnostics) is a medical device company that provides cardio respiratory health solutions. The company provides PFT, metabolic CPET and CPX and indirect calorimetry products. Its PFT products include plethysmograph, pulmonary function systems, spirometry and forced …
  • Electrovaya Inc. (EFL)-エネルギー分野:企業M&A・提携分析
    Summary Electrovaya Inc. (Electrovaya) is a vertically integrated energy storage solutions company which designs, develops, manufactures, and markets power technology products. Its offerings include lithium ion super polymer batteries, battery systems, and battery related products and accessories. T …
  • Escalier Biosciences BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Escalier Biosciences BV (Escalier Biosciences) is a biopharmaceutical company, which develops small molecule medicines for the treatment of autoimmune disorders. Its pipeline products include topical and oral RAR-related orphan receptor gamma inverse agonists. Inhibition of RAR-related orpha …
  • Tohoku Electric Power Company, Incorporated:企業の戦略・SWOT・財務情報
    Tohoku Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Tohoku Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • K2M Inc-医療機器分野:企業M&A・提携分析
    Summary K2M Inc (K2M), a subsidiary of K2M Group Holdings Inc is a medical device company that designs, develops and markets spine solutions products for the treatment of spinal pathologies. The company offers complex spine, minimally invasive, degenerative and biologics products. It offers complex …
  • Brookshire Grocery Co:企業の戦略・SWOT・財務情報
    Brookshire Grocery Co - Strategy, SWOT and Corporate Finance Report Summary Brookshire Grocery Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆